Leukemia Home > Bosulif and Pfizer

By slowing down or stopping the production of abnormal blood cells, Bosulif® (bosutinib) can help treat a certain type of leukemia in adults. This prescription medicine comes as a tablet and is taken once a day. It is specifically designed to treat a specific type of leukemia called Philadelphia chromosome-positive chronic myelogenous leukemia. It is used when other treatment has failed or cannot be tolerated.
Bosulif is made by Pfizer Labs. It is only available in brand-name form at this time, as patents currently prevent any company from making a generic version of this drug.
(Click Bosulif to read the full-length overview of this chemotherapy drug.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):



Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.